Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 2
1982 1
1989 1
1990 1
1993 3
1994 4
1995 6
1996 5
1997 6
1998 5
1999 6
2000 5
2001 14
2002 15
2003 9
2004 17
2005 14
2006 10
2007 13
2008 13
2009 15
2010 9
2011 10
2012 15
2013 13
2014 19
2015 19
2016 20
2017 26
2018 22
2019 20
2020 29
2021 17
2022 19
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Breast Cancer Epidemiology, Prevention, and Screening.
Winters S, Martin C, Murphy D, Shokar NK. Winters S, et al. Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10. Prog Mol Biol Transl Sci. 2017. PMID: 29096890 Review.
Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among women. ...Mutations in the BRCA 1 and BRCA 2 tumor suppressor genes are significantly associated with the development of breast and ovar
Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among women. …
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.
Yoshida R. Yoshida R. Breast Cancer. 2021 Nov;28(6):1167-1180. doi: 10.1007/s12282-020-01148-2. Epub 2020 Aug 29. Breast Cancer. 2021. PMID: 32862296 Free PMC article. Review.
Although the most common breast cancer susceptibility genes are BRCA1 and BRCA2, which are also associated with the risk of developing ovarian and pancreatic cancer, advances in next-generation sequencing (NGS) analysis technology enabled the discovery …
Although the most common breast cancer susceptibility genes are BRCA1 and BRCA2, which are also associated with the risk of de …
BRCA genes: BRCA 1 and BRCA 2.
Varol U, Kucukzeybek Y, Alacacioglu A, Somali I, Altun Z, Aktas S, Oktay Tarhan M. Varol U, et al. J BUON. 2018 Jul-Aug;23(4):862-866. J BUON. 2018. PMID: 30358186 Free article. Review.
BRCA1 and BRCA2 are the genes related with breast and ovarian cancer. They have function in DNA repair processes and thus they are tumor suppressor genes. ...Members of the families with BRCA mutations have an increased risk for early onset of breast cancer a …
BRCA1 and BRCA2 are the genes related with breast and ovarian cancer. They have function in DNA repair processes and thus they …
Endometriosis.
Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Zondervan KT, et al. Nat Rev Dis Primers. 2018 Jul 19;4(1):9. doi: 10.1038/s41572-018-0008-5. Nat Rev Dis Primers. 2018. PMID: 30026507 Review.
Endometriosis is a common inflammatory disease characterized by the presence of tissue outside the uterus that resembles endometrium, mainly on pelvic organs and tissues. ...Diagnosis is reliably established only through surgical visualization with histological verificatio …
Endometriosis is a common inflammatory disease characterized by the presence of tissue outside the uterus that resembles endometrium, …
Cancer genetics and breast cancer.
Huber-Keener KJ. Huber-Keener KJ. Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:3-11. doi: 10.1016/j.bpobgyn.2022.01.007. Epub 2022 Jan 31. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35272929 Review.
This chapter focuses on how genes play a role in breast cancer risk, why certain genes are commonly involved in hereditary breast cancer, and what are the specific genes and genetic syndromes that put patients at risk for breast cancer. Hereditary cancer
This chapter focuses on how genes play a role in breast cancer risk, why certain genes are commonly involved in hereditary breast …
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.
Yoshida K, Miki Y. Yoshida K, et al. Cancer Sci. 2004 Nov;95(11):866-71. doi: 10.1111/j.1349-7006.2004.tb02195.x. Cancer Sci. 2004. PMID: 15546503 Free article. Review.
BRCA1 (BReast-CAncer susceptibility gene 1) and BRCA2 are tumor suppressor genes, the mutant phenotypes of which predispose to breast and ovarian cancers. ...Finally, the reasons why mutations in BRCA genes lead to the development of breast and ovar
BRCA1 (BReast-CAncer susceptibility gene 1) and BRCA2 are tumor suppressor genes, the mutant phenotypes of which predis …
Hereditary pancreatic cancer.
Abe K, Kitago M, Kitagawa Y, Hirasawa A. Abe K, et al. Int J Clin Oncol. 2021 Oct;26(10):1784-1792. doi: 10.1007/s10147-021-02015-6. Epub 2021 Sep 2. Int J Clin Oncol. 2021. PMID: 34476650 Free PMC article. Review.
Pancreatic cancer is associated with both family and hereditary cancer syndromes. ...Since poly-ADP-ribose polymerase (PARP) inhibitor has been shown to be effective in improving the prognosis of BRCA-positive pancreatic cancer as well as hereditary breast an …
Pancreatic cancer is associated with both family and hereditary cancer syndromes. ...Since poly-ADP-ribose polymerase (PARP) i …
Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
Bellcross CA. Bellcross CA. Obstet Gynecol Clin North Am. 2022 Mar;49(1):117-147. doi: 10.1016/j.ogc.2021.11.005. Obstet Gynecol Clin North Am. 2022. PMID: 35168766 Review.
This article provides an update on hereditary breast and ovarian cancer syndrome (HBOC) associated with pathogenic variants (PVs) in BRCA1/2. ...Obstetricians and gynecologists familiar with these concepts can identify and improve the quality of care for women and f …
This article provides an update on hereditary breast and ovarian cancer syndrome (HBOC) associated with pathogenic variants (P …
Appropriate Selection of PARP Inhibitors in Ovarian Cancer.
Smith M, Pothuri B. Smith M, et al. Curr Treat Options Oncol. 2022 Jun;23(6):887-903. doi: 10.1007/s11864-022-00938-4. Epub 2022 Apr 12. Curr Treat Options Oncol. 2022. PMID: 35412195 Review.
Poly-ADP-ribose polymerase inhibitors (PARPi) are a class of anti-cancer drugs that target DNA repair pathways and have shown promising efficacy in patients with ovarian cancer in recent clinical trials. To date, there have been 9 FDA PARPi approvals/indicati …
Poly-ADP-ribose polymerase inhibitors (PARPi) are a class of anti-cancer drugs that target DNA repair pathways and have shown promisi …
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses.
Tanha K, Mottaghi A, Nojomi M, Moradi M, Rajabzadeh R, Lotfi S, Janani L. Tanha K, et al. J Ovarian Res. 2021 Nov 11;14(1):153. doi: 10.1186/s13048-021-00911-z. J Ovarian Res. 2021. PMID: 34758846 Free PMC article. Review.
Following cervical and uterine cancer, ovarian cancer (OC) has the third rank in gynecologic cancers. ...Two hundred seventy-seven articles met our inclusion criteria, 226 of which included in the meta-analysis. Most commonly reported genetic factors were MTH …
Following cervical and uterine cancer, ovarian cancer (OC) has the third rank in gynecologic cancers. ...Two hundred se …
375 results